... specialist, and just gives 20-30 norco a day, eek 2 yrs what to do, left lower leg fused
Change doctors, seek a second opinion elsewhere. I know that you are in great pain, and doctors are human, and they get jealous too and refuse to admit sometimes that they can't help someone anymore. 20 to 30 Norco a day is too much, there are longer acting pain meds, and you should probably be on one of those. Try asking several pharmacists who in your area may treat your condition, and go with one of the recommendations. If you have a medical college nearby, check with them, they may have a doctor who will help you, who knows the latest treatments. I hope you get some relief soon. Patti
Sorry for such a long post. I thought you may be interested in this study being conducted. Hope this is helpful and wish you find relief soon!
This study will examine the effectiveness of the drug neurotropin in treating chronic pain after injury to a limb or a large nerve.
Two groups of patients will participate in this study: patients with complex regional pain syndrome type 1, or CRPS-I (also called reflex sympathetic dystrophy) and patients with complex regional pain syndrome type 2, or CRPS-II. CRPS-I is pain that develops after relatively minor injury to an arm or leg, but lasts much longer and is much more severe than would normally be expected. CRPS-II is pain resulting from injury to a large nerve. Candidates will have a history and physical examination, blood tests, and electrocardiogram. Participants will undergo the following tests and procedures:
Patients with CRPS I and II will receive an individualized regimen of physical therapy and standard treatment to control their pain. In addition, they will receive neurotropin or placebo tablets for 5 weeks, then no trial medicine for at least 1 week, and then the other trial drug for the next 5 weeks. That is, patients who took placebo the first 5 weeks will take neurotropin the second 5 weeks and vice versa. Neither the patients nor the doctors will know who received which drug during the two intervals until the study is over. Patients will complete questionnaires about their pain, quality of life, and ability to perform daily living activities. They will have various tests to measure pain (such as sensitivity to heat and cold, to an electric current, to a mild pin prick, etc.); to provide information about changes in their condition (such as tests of range of motion of joints and limb size); to measure blood circulation and sweating in the arm or leg (such as measurements of blood flow to the limb, skin temperature, and sweat production), and other procedures.
National Institute of Nursing Research (NINR)
Type: Participants currently recruited/enrolled
Gender: Male & Female
Referral Letter Required: No
Population Exclusion(s): Children
CRPS patients are referred with a diagnosis of CRPS-I or CRPS-II in one limb only, based on pain (1) that is post-traumatic and spread beyond the region of the injury; (2) has persisted for more than 2 weeks; and (3) is associated with swelling, altered skin color or skin temperature, altered sweating, allodynia or hyperesthesia or limitation of active movement. Atrophic changes in skin, hair loss or nail changes, or disuse atrophy of skeletal muscle may be present.
Both sexes are to be studied.
All ethnic and racial groups can participate.
Patients must be willing to return to NIH for follow-up evaluation under this protocol.
Pregnant and lactating women are excluded.
Based on the oral surgeon's postoperative diagnosis, any extraction which is classified as producing unusual surgical trauma will result in exclusion from the remainder of the study.
Dental subjects will also be excluded if they are not adequately sedated by midazolam alone and require intraoperative administration of an opioid drug such as fentanyl, administration of greater than 14.4 ml of local anesthetic (2% lidocaine with 1:100,000 epinephrine), or postoperative administration of a steroid for possible injury to the inferior alveolar nerve.
Patients referred with CRPS-I or CRPS II who have abnormal screening test results or who have non-traumatic disorders to which pain may be attributed (gout, malignancy, arthritis, etc.) will be excluded.
Any patients who have had ablative procedures for treatment of their neuropathic pain disorder will not be eligible for inclusion in this study.
Patients who have a positive HIV result will be excluded.
Subjects with obviously impaired mental capacity that precludes informed consent and ability to provide adequate self-ratings are to be excluded.
Currently Not Provided
Reflex Sympathetic Dystrophy
Sympathetic Nervous System
Chronic Regional Pain Syndrome
CRPS-I Reflex Sympathetic Dystrophy
National Institute of Nursing Research
Patient Recruitment and Public Liaison Office
10 Cloister Court
Bethesda, Maryland 20892-4754
Toll Free: 1-800-411-1222
TTY: 301-594-9774 (local),1-866-411-1010 (toll free)
Reflex sympathetic dystrophy: changing concepts and taxonomy
IASP diagnostic criteria for complex regional pain syndrome: a preliminary empirical validation study International Association for the Study of Pain
External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteria International Association for the Study of Pain
Clinical Trials Number:
- Norco Information for Consumers
- Norco Information for Healthcare Professionals (includes dosage details)
- Side Effects of Norco (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 18 Nov 2009 • 4 answers
Posted 17 Jan 2012 • 3 answers
Reflex Sympathetic Dystrophy Syndrome - Did anyone see Dr OZ with Paula Abdul talking about RDS for?
Posted 24 May 2012 • 8 answers
Posted 16 Nov 2012 • 2 answers
Reflex Sympathetic Dystrophy Syndrome - I have had rsd four times or what you could call flare up's?
Posted 31 Oct 2015 • 1 answer